Clinical bottom line
Uterine arteriovenous fistulas (AVFs), a subset of uterine arteriovenous malformations (AVMs), represent a rare but potentially life-threatening cause of abnormal uterine bleeding. Recent advances emphasize minimally invasive diagnostic modalities and fertility-preserving therapeutic options. Uterine artery embolization (UAE) remains a frontline intervention, often combined with adjunctive medical or surgical treatments to improve outcomes and preserve reproductive potential. Emerging laparoscopic and hysteroscopic techniques offer promising alternatives for patients with persistent or recurrent disease, particularly when embolization fails or is contraindicated.
What the evidence shows
Diagnosis of uterine AVFs has improved with enhanced imaging techniques, including transvaginal Doppler ultrasound and magnetic resonance angiography, facilitating early detection and characterization of vascular anatomy. Li He et al. (2021) demonstrated that UAE followed by gonadotropin-releasing hormone (GnRH) agonist therapy effectively controls bleeding and promotes lesion regression, with favorable preservation of fertility. This combined approach leverages embolization to occlude abnormal vessels and hormonal suppression to reduce vascular proliferation.
For patients with persistent or recurrent AVFs after embolization, minimally invasive surgical options have gained traction. Bettaiah Ramesh et al. (2018) reported success with laparoscopic uterine artery ligation, offering a fertility-sparing alternative that directly interrupts aberrant blood flow. Similarly, Zhang et al. (2018) described a combined laparoscopic and hysteroscopic approach to excise AVF lesions while preserving uterine integrity, highlighting the feasibility of tailored, fertility-preserving interventions.
More recently, Matthaeus et al. (2024) provided evidence supporting fertility-preserving laparoscopic surgery after failed UAE, emphasizing the importance of individualized management strategies in complex cases. These surgical innovations complement embolization by addressing residual or inaccessible fistulas, potentially reducing the need for hysterectomy.
Additionally, Pereira Nigel et al. (2018) underscored the importance of recognizing leiomyoma-endometrial fistulas as a differential diagnosis in persistent vaginal discharge post-UAE, suggesting that careful histopathological evaluation is critical to guide appropriate management.
Caveats and uncertainty
The rarity of uterine AVFs limits large-scale randomized trials, and most evidence derives from case series and retrospective cohorts, which may introduce selection bias. The heterogeneity of lesion size, location, and patient fertility desires complicates standardized treatment algorithms. While UAE is widely accepted as first-line therapy, its impact on long-term fertility remains incompletely defined, warranting cautious patient counseling.
Surgical approaches, though promising, require advanced laparoscopic and hysteroscopic expertise and may not be universally available. The optimal timing and sequencing of combined embolization and medical or surgical therapies remain areas of active investigation. Furthermore, the risk of recurrence and long-term vascular remodeling after treatment necessitates ongoing surveillance, but consensus on follow-up protocols is lacking.
Histopathological differentiation between AVFs and other vascular uterine anomalies, such as AVMs or leiomyoma-associated fistulas, can be challenging, underscoring the need for multidisciplinary diagnostic evaluation.
How this may change practice
Clinicians should maintain a high index of suspicion for uterine AVFs in women presenting with unexplained abnormal uterine bleeding, especially following uterine instrumentation or pregnancy-related events. Adoption of advanced imaging can facilitate earlier diagnosis and tailored treatment planning.
UAE combined with GnRH agonist therapy represents a pragmatic first-line approach balancing efficacy and fertility preservation. For refractory cases, referral to centers with expertise in minimally invasive laparoscopic and hysteroscopic surgery may improve outcomes and avoid hysterectomy.
Multidisciplinary collaboration among interventional radiologists, gynecologic surgeons, and pathologists is essential to optimize diagnostic accuracy and therapeutic sequencing. Patient counseling should incorporate current evidence on fertility outcomes and recurrence risks, emphasizing individualized decision-making.
Future research should focus on prospective studies to define standardized treatment pathways, long-term reproductive outcomes, and optimal surveillance strategies.